Abstract:Background: Refractory chronic migraine affects approximately 4% of the population worldwide and results in severe pain, lifestyle limitations, and decreased quality of life. Occipital nerve stimulation (ONS) refers to the electric stimulation of the distal branches of greater and lesser occipital nerves; the surgical technique has previously been described and has demonstrated efficacy in the treatment of a wide variety of headache disorders. Objectives: The aim of this study is to evaluate the long-term efficacy and tolerability of ONS for medically intractable chronic migraine. Study design: Prospective, long-term, open-label, uncontrolled observational study. Setting: Single public university hospital. Methods: Patients who met the International Headache Society criteria for chronic migraine, all of them having been previously treated with other therapeutic alternatives, and who met all inclusion and exclusion criteria for neurostimulation, received the implantation of an ONS system after a positive psychological evaluation and a positive response to a preliminary occipital nerve blockage. The implantation was performed in 2 phases: a 10 day trial with implanted occipital leads connected to an external stimulator and, if more than 50% pain relief was obtained, permanent pulse generator implantation and connection to the previously implanted leads. After the surgery, the patients were thoroughly evaluated annually using different scales: pain Visual Analogue Scale (VAS), number of migraine attacks per month, sleep quality, functionality in social and labor activities, reduction in pain medication, patient satisfaction, tolerability, and reasons for termination. The average follow-up time was 9.4 ± 6.1 years, and 31 patients completed a 7-year follow-up period. Results: Thirty-seven patients were enrolled and classified according to the location and quality of their pain, accompanying symptoms, work status, and psychological effects. Substantial pain reduction was obtained in most patients, and the VAS decreased by 4.9 ± 2.0 points. These results remained stable over the follow-up period. Five of the 35 permanently implanted patients with migraine attacks at baseline were free from these attacks at their last visits, whereas the pain severity decreased 3.8 ± 2.5 (according to the VAS) in the remaining patients. Seven of the 35 permanent implanted devices were definitively removed: 2 devices because of treatment inefficacy, and 5 devices because the patients were asymptomatic and considered to be cured from their pain, even with the stimulation off. Systemic side effects were not observed. Limitations: Limitations of the current study include its uncontrolled and open-label design. Additionally, not all patients completed the 7-year follow-up period. Conclusions: We consider that the trigemino-cervical autonomous and cervical connection may explain why ONS might relieve chronic migraine pain, but this is just a theoretical explanation which should be demonstrated in future studies. The results achieved in this study suggest that ONS may provide long-term benefits for patients with medically intractable chronic migraine. These outcomes are slightly better than previous reports and were maintained over the 7-year follow-up. We believe that an accurate selection of patients, realization of diagnostic occipital nerve blocks, psychological evaluations, rigorous surgical technique, and appropriate parameter programming helped us achieve these outcomes. Key words: Refractory chronic migraine, headache, occipital nerve stimulatino, peripheral nerve stimulation, occipital nerve block.

Noninvasive neurostimulation methods for migraine therapy: The available evidence

Non-Invasive Neurostimulation Methods for Acute and Preventive Migraine Treatment—A Narrative Review

Non-invasive Brain Stimulation Interventions for Management of Chronic Central Neuropathic Pain: a Scoping Review Protocol

Central and Peripheral Neural Targets for Neurostimulation of Chronic Headaches

Clinical utility of implantable neurostimulation devices in the treatment of chronic migraine

Noninvasive Vagus Nerve Stimulation for Migraine: a Systematic Review and Meta-Analysis of Randomized Controlled Trials

Migraine Treatment: Towards New Pharmacological Targets

Neuromodulation Techniques for Headache Management

Potential treatment targets for migraine: emerging options and future prospects

Migraine prevention by noninvasive electrical fastigial nucleus stimulation: a multi-center, randomized, double-blind, sham-controlled trial

Non-invasive vagus nerve stimulation for primary headache: A clinical update

Non-invasive cortical stimulation for drug-resistant pain

Future targets for migraine treatment beyond CGRP

Non-Invasive Electric and Magnetic Brain Stimulation for the Treatment of Fibromyalgia

Occipital Nerve Stimulation for Migraine: A Systematic Review

Management of auricular transcutaneous neuromodulation and electro-acupuncture of the vagus nerve for chronic migraine: a systematic review

A systematic review of high-frequency transcranial magnetic stimulation on motor cortex areas as a migraine preventive treatment

Migraine: Pathophysiology, Pharmacology, Treatment and Future Trends

Occipital Nerve Stimulation for Refractory Chronic Migraine: Results of a Long-Term Prospective Study

Novel strategies for the treatment of migraine attacks via the CGRP, serotonin, dopamine, PAC1, and NMDA receptors

Cervical Spinal Cord Stimulation for the Treatment of Headache Disorders: A Systematic Review